Corneal Ectasia
📧 Sign up to get email alerts when something new happens for Corneal Ectasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Corneal Collagen Cross-Linking (CXL) Performed With "Epi-ON" Versus "Epi-OFF" in Eyes With Keratoconus and Other Corneal Ectatic Disorders [Phase 3]
Phase 3 clinical trial update comparing epi-on versus epi-off corneal collagen cross-linking in keratoconus and corneal ectatic disorders.
-
FDA approval · 2019-01-25FDA Approved: PHOTREXA CROSS-LINKING KIT — Supplemental Application (Glaukos Corporation)
The FDA approved a supplemental application for the Photrexa Cross-Linking Kit, including riboflavin 5-phosphate ophthalmic solution, used t…
-
FDA approval · 2018-10-29FDA Approved: PHOTREXA CROSS-LINKING KIT — Supplemental Application (Glaukos Corporation)
FDA approved a supplemental application for the Photrexa Cross-Linking Kit (riboflavin 5-phosphate ophthalmic) by Glaukos Corporation, suppo…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery [Phase 3]
Phase 3 trial evaluating the safety and efficacy of corneal collagen cross-linking for keratoconus or corneal ectasia after refractive surge…
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: Safety and Effectiveness of Corneal Crosslinking (CXL): Keratoconus and Post-Refractive Ectasia [Phase 3]
A Phase 3 clinical trial is evaluating corneal crosslinking for keratoconus and post-refractive corneal ectasia, assessing safety and effect…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Corneal Crosslinking in Keratoconus and Corneal Ectasia [Phase 2, Phase 3]
A phase 2/phase 3 trial of corneal crosslinking for progressive keratoconus and corneal ectasia has been withdrawn.
-
CLINICAL_TRIALS research · 2016-08-30Clinical Trial Update: Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL). [Phase 1, Phase 2]
Clinical trial update on conventional versus accelerated corneal collagen cross-linking for keratoconus and corneal ectasia, covering Phase …
-
FDA approval · 2016-04-15FDA Approved: PHOTREXA CROSS-LINKING KIT — Original Application (Glaukos Corporation)
FDA approved Photrexa Cross-Linking Kit (riboflavin 5-phosphate ophthalmic) from Glaukos for corneal collagen cross-linking to slow progress…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2 [Phase 1]
A Phase 1 clinical trial evaluating the safety and effectiveness of collagen cross-linking at irradiances of 9 and 18 mW/cm2 for keratoconus…
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: Combined CXL//UV and PRK or LASIK in Forme Fruste Keratoconus or Eyes With Potential Risk of Ectasia
A clinical trial evaluating the combination of corneal collagen cross-linking with UV illumination and PRK or LASIK in eyes with forme frust…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Eye Rubbing and Transient Change in Corneal Parameters [NA]
A clinical trial update reports a transient change in corneal parameters associated with eye rubbing in patients with corneal ectasia.
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia [Phase 2]
Phase 2 clinical trial update assessing UVA-Riboflavin crosslinking for keratoconus and corneal ectasia; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2010-09-02Clinical Trial Update: Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia [Phase 2, Phase 3]
Clinical trial update on corneal collagen cross-linking for progressive keratoconus and corneal ectasia. Phase 2/3 trials completed.
-
CLINICAL_TRIALS research · 2010-05-14Clinical Trial Update: Riboflavin-UVA Induced Collagen Crosslinking Treatment for Corneal Ectasia [NA]
The document provides a clinical trial update for riboflavin-UVA induced collagen crosslinking as a treatment for corneal ectasia.